Goette, Andreas
Merino, Jose L.
De Caterina, Raffaele
Huber, Kurt
Heidbuchel, Hein
Jin, James
Lip, Gregory Y. H.
Funding for this research was provided by:
Daiichi-Sankyo
Article History
Received: 8 October 2019
Accepted: 13 March 2020
First Online: 31 March 2020
Compliance with ethical standards
:
: Andreas Goette, MD, has served as a consultant for Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer; and a speaker for AstraZeneca, Bayer, Berlin-Chemie, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, Pfizer, and Sanofi-Aventis. Jose L. Merino, MD, has served on the Speakers Bureau for Cardiome, Daiichi Sankyo, Medtronic, and St. Jude Medical; and has served as a consultant for Bayer, Biotronik, Boston Scientific, Bristol-Myers Squibb, Cardiome, Daiichi Sankyo, LivaNova, Medtronic, Pfizer, Sanofi, and St. Jude Medical. Raffaele De Caterina, MD, has received research grants from Pfizer, Daiichi Sankyo, Novartis, Merck Sharp, and Dohme; and has received honoraria from Sanofi, Boehringer-Ingelheim, Bayer, Bristol-Myers Squibb, Pfizer, and Portola. Kurt Huber, MD, has received lecture fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer. Hein Heidbuchel, MD, has served as a consultant or speaker for Boehringer-Ingelheim, Bayer, Bristol-Myers Squibb, Cardiome, Daiichi-Sankyo, Pfizer, and St. Jude Medical. James Jin, PhD, is an employee of Daiichi Sankyo Pharma Development. Gregory Y.H. Lip, MD, has served as a consultant for Bayer/Janssen, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Medtronic, Novartis, and Verseon; and a speaker for Bayer, Bristol-Myers Squibb/Pfizer, Boehringer Ingelheim, Daiichi Sankyo, and Medtronic. No fees were directly received personally.